Prosztatarák: vizsgálatok itt: Kína
253 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
- Where
- Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
- Életkor
- 18 év to 100 év
- People
- 1000
- Run by
- Xijing Hospital
See details and how to joinNCT07474142 - No phaseTaking peopleComparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 592
- Run by
- Peking University First Hospital
See details and how to joinNCT07460843 - 1. fázisNot yet taking people in KínaA Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 65
- Run by
- Gan & Lee Pharmaceuticals.
See details and how to joinNCT07468396 - 2. fázisTaking peopleA Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer
- Where
- Nanjing, Tianjin
- Életkor
- 18 év to 80 év
- People
- 218
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07230106 - No phaseNot yet taking people in KínaRezvilutamide for High-Risk Prostate Cancer After Surgery
- Where
- Fuzhou
- Életkor
- 18 év to 95 év
- People
- 33
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT07444983 - 1/2. fázisTaking peopleBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
- Where
- Beijing
- Életkor
- 8 év to 85 év
- People
- 85
- Run by
- Essen Biotech
See details and how to joinNCT07410494 - 1/2. fázisTaking peopleEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Where
- Beijing
- People
- 83
- Run by
- Essen Biotech
See details and how to joinNCT07410676 - Korai 1. fázisNot yet taking people in KínaSafety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer
- Where
- Shanghai
- Életkor
- 18 év to 85 év
- People
- 40
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT07389174 - Korai 1. fázisNot yet taking people in KínaSafety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Where
- Shanghai
- Életkor
- 18 év to 85 év
- People
- 10
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT07389187 - 3. fázisTaking peopleA Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 370
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07311694 - 2. fázisNot yet taking people in KínaPSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows
- Where
- Qingdao
- Életkor
- 18 év and over
- People
- 27
- Run by
- Haitao Niu, MD
See details and how to joinNCT07387510 - Korai 1. fázisNot yet taking people in KínaSafety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Where
- Beijing, Mianyang
- Életkor
- 18 év and over
- People
- 15
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07381582 - No phaseTaking peopleThe Development and Validation of MRI-AI-based Predictive Models for csPCa
- Where
- Beijing
- People
- 3000
- Run by
- Peking University First Hospital
See details and how to joinNCT06842264 - No phaseNot yet taking people in KínaDevelopment and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 150
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07376057 - Korai 1. fázisTaking peopleStudy of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 10
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07156045 - 1/2. fázisTaking peopleThe Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer
- Where
- Fuzhou
- Életkor
- 18 év to 90 év
- People
- 6
- Run by
- First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07363382 - 1/2. fázisTaking peopleSequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Where
- Fuzhou
- Életkor
- 18 év to 90 év
- People
- 9
- Run by
- First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07363486 - Korai 1. fázisTaking peopleAn Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 15
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07298239 - 2/3. fázisTaking peopleA Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
- Where
- Qingdao, Shanghai
- Életkor
- 40 év to 75 év
- People
- 300
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT03258320 - 1. fázisTaking peopleA Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
- Where
- Hangzhou, Shanghai, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Phrontline Biopharma
See details and how to joinNCT07181473 - No phaseTaking peopleStudy of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis
- Where
- Hefei
- Életkor
- 50 év and over
- People
- 2000
- Run by
- Anhui Medical University
See details and how to joinNCT07112599 - 1/2. fázisTaking peopleA Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer
- Where
- Tianjin, Wuxi
- Életkor
- 18 év and over
- People
- 55
- Run by
- Yunhe Pharmaceutical (Tianjin) Co., Ltd
See details and how to joinNCT06970119 - No phaseTaking peopleAdaptive Radiotherapy for Genitourinary Cancers
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 60
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07324798 - No phaseNot yet taking people in KínaPropranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study
- Where
- Nanjing
- Életkor
- 18 év to 85 év
- People
- 30
- Run by
- Zhongda Hospital
See details and how to joinNCT07311915 - No phaseTaking peopleEstablishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 3000
- Run by
- Peking University First Hospital
See details and how to joinNCT07319923